FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 6,318,525 shares of Vor Biopharma Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC reported 6,318,525 shares of Vor Biopharma Inc. common stock beneficially owned, representing 10.7% of the class.
  • Sole voting power: FMR LLC reported sole voting power over 6,317,873 shares, with 0 shares subject to shared voting power.
  • Sole dispositive power: FMR LLC reported sole dispositive power over 6,318,525 shares, with 0 shares subject to shared dispositive power.
  • Abigail P. Johnson: Also named as a reporting person, Johnson reported 6,318,525 shares beneficially owned (10.7% of class), with sole dispositive power over all shares and 0 sole or shared voting power.
  • Triggering event date: The date of the event requiring this filing was September 30, 2026.
  • Third-party interest noted: According to the filing, one or more other persons hold the right to receive dividends or proceeds from the sale of the common stock, though no single other person's interest exceeds 5% of the total outstanding shares.

FMR LLC and Abigail P. Johnson Disclose Ownership Position in Vor Biopharma

FMR LLC, organized in Delaware, and Abigail P. Johnson, a United States citizen, jointly filed Amendment No. 2 to a Schedule 13G with the SEC disclosing their beneficial ownership in Vor Biopharma Inc. (NASDAQ:VOR). The filing, signed November 4, 2026 and covering the event date of September 30, 2026, identifies FMR LLC as a parent holding company (type "HC") and Abigail P. Johnson as an individual (type "IN"). Vor Biopharma's principal executive offices are listed at 500 Boylston Street, Suite 1350, Boston, MA 02116.

According to the filing, FMR LLC holds sole voting power over 6,317,873 shares and sole dispositive power over 6,318,525 shares, with no shared voting or dispositive power reported. Abigail P. Johnson is reported to hold sole dispositive power over the same 6,318,525 shares, but 0 sole or shared voting power. Both reporting persons report an aggregate beneficial ownership of 6,318,525 shares, equal to 10.7% of the class, based on common stock with CUSIP number 929033207.

The filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Item 7 of the filing directs readers to Exhibit 99 for the identity and classification of the relevant subsidiary through which the position is held. The filing was signed by Stephanie J. Brown under powers of attorney granted on behalf of both FMR LLC and Abigail P. Johnson.

What Was Disclosed

FMR LLC and Abigail P. Johnson filed Amendment No. 2 to Schedule 13G reporting combined beneficial ownership of 6,318,525 shares, or 10.7%, of Vor Biopharma Inc. common stock as of September 30, 2026, with no shared voting or dispositive power reported by either party.